MicroRNA‑210 negatively regulates the radiosensitivity of nasopharyngeal carcinoma cells

Li,Bo‑Yi; Luo,Yi; Zhao,Wen‑Si; Zhang,Lu; Zhou,Han‑Jing; Zou,Yu‑Chun; Zhang,Tao

doi:10.3892/mmr.2017.6694

MicroRNA‑210 negatively regulates the radiosensitivity of nasopharyngeal carcinoma cells

Authors:
- Bo‑Yi Li
- Yi Luo
- Wen‑Si Zhao
- Lu Zhang
- Han‑Jing Zhou
- Yu‑Chun Zou
- Tao Zhang
View Affiliations

Affiliations: Department of Oncology, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Oncology, Shizhu County People's Hospital, Chongqing 409100, P.R. China
Published online on: June 6, 2017 https://doi.org/10.3892/mmr.2017.6694
Pages: 1401-1408

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radiotherapy is one of the primary methods of treatment of malignant tumors, however, resistance to radiation is a major problem. The reasons for the radioresistance are still poorly understood. However, it is generally accepted that microRNAs (miRNAs or miRs) can regulate the radiosensitivity of tumors. The present study therefore aimed to identify specific miRNAs and their effects on radioresistant cells. More specifically, the aim was to investigate specific miRNAs and their effects on radioresistant tumor cells. The radioresistant tumor cells (CNE‑2R) were established using a dose gradient method, and the miRNA expression profiles of CNE‑2R cells and the parental cells (CNE‑2) were determined. The expression of miR‑210 in CNE‑2R cells was significantly higher than in CNE‑2 cells. CNE‑2R cells were transfected with LV‑hsa‑miR‑210‑inhibitor, and CNE‑2 cells were transfected with LV‑hsa‑miR‑210. The expression of miR‑210 was confirmed by reverse transcription quantitative‑polymerase chain reaction. The percentages of CNE‑2R‑miR‑210‑inhibitor and CNE‑2 cells in the G2/M phase were higher than in the CNE‑2R and CNE‑2‑miR‑210 cells, and the percentages of cells in S phase were lower than in the CNE‑2R and CNE‑2‑miR‑210 cells. Following 4 Gy of radiation, CNE‑2R‑miR‑210‑inhibitor and CNE‑2 cells, which express low levels of miR‑210, had a higher apoptosis rate than CNE‑2R and CNE‑2‑miR‑210 cells. Following 4, 8 and 12 Gy of radiation, cell viability and survival fraction of CNE‑2R‑miR‑210‑inhibitor cells were lower than those of CNE‑2R and CNE‑2‑miR‑210 cells, and similar to those of CNE‑2 cells. Together, these findings strongly suggest that miR‑210 negatively regulates the radiosensitivity of tumor cells, and may therefore have therapeutic potential for the treatment of radiation resistance.

View Figures

View References

1	Tamura M, Ito H and Matsui H: Radiotherapy for cancer using X-ray fluorescence emitted from iodine. Sci Rep. 7:436672017. View Article : Google Scholar : PubMed/NCBI
2	Serbanescu GL, Gruia MI, Bara M and Anghel RM: The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Med Life. 10:992017.PubMed/NCBI
3	Yoon SM, Shaikh T and Hallman M: Therapeutic management options for stage III non-small cell lung cancer. World J Clin Oncol. 8:1–20. 2017. View Article : Google Scholar : PubMed/NCBI
4	Son SH, Choi KH and Kim SW: Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer. PLoS One. 12:e01735522017. View Article : Google Scholar : PubMed/NCBI
5	Zhang N, Liang SB, Deng YM, Lu RL, Chen HY, Zhao H, Lv ZQ, Liang SQ, Yang L, Liu DS and Chen Y: Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: A retrospective study. BMC cancer. 14:1362014. View Article : Google Scholar : PubMed/NCBI
6	Chen ZT, Liang ZG and Zhu XD: A Review: Proteomics in Nasopharyngeal Carcinoma. Int J Mol Sci. 16:15497–15530. 2015. View Article : Google Scholar : PubMed/NCBI
7	Chen MY, Jiang R, Guo L, Zou X, Liu Q, Sun R, Qiu F, Xia ZJ, Huang HQ, Zhang L, et al: Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis. Chin J Cancer. 32:604–613. 2013. View Article : Google Scholar : PubMed/NCBI
8	Hutajulu SH, Kurnianda J, Tan IB and Middeldorp JM: Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma. Ther Clin Risk Manag. 10:721–736. 2014. View Article : Google Scholar : PubMed/NCBI
9	Mendell JT and Olson EN: MicroRNAs in stress signaling and human disease. Cell. 148:1172–1187. 2012. View Article : Google Scholar : PubMed/NCBI
10	Pedersen CC, Refsgaard JC, Østergaard O, Jensen LJ, Heegaard NH, Borregaard N and Cowland JB: Impact of microRNA-130a on the neutrophil proteome. BMC immunol. 16:702015. View Article : Google Scholar : PubMed/NCBI
11	Li J, Dong G, Wang B, Gao W and Yang Q: miR-543 promotes gastric cancer cell proliferation by targeting SIRT1. Biochem Biophys Res Commun. 469:15–21. 2016. View Article : Google Scholar : PubMed/NCBI
12	Lee D, Sun S, Zhang XQ, Zhang PD, Ho AS, Kiang KM, Fung CF, Lui WM and Leung GK: MicroRNA-210 and endoplasmic reticulum chaperones in the regulation of chemoresistance in glioblastoma. J Cancer. 6:227–232. 2015. View Article : Google Scholar : PubMed/NCBI
13	Li Y, Han W, Ni TT, Lu L, Huang M, Zhang Y, Cao H, Zhang HQ, Luo W and Li H: Knockdown of microRNA-1323 restores sensitivity to radiation by suppression of PRKDC activity in radiation-resistant lung cancer cells. Oncol Rep. 33:2821–2828. 2015.PubMed/NCBI
14	Chan SY, Choy KW, Tsao SW, Tao Q, Tang T, Chung GT and Lo KW: Authentication of nasopharyngeal carcinoma tumor lines. Int J Cancer. 122:2169–2171. 2008. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Shi RC, Meng AF, Zhou WL, Yu XY, Huang XE, Ji AJ and Chen L: Effects of home nursing intervention on the quality of life of patients with nasopharyngeal carcinoma after radiotherapy and chemotherapy. Asian Pac J Cancer Prev. 16:7117–7121. 2015. View Article : Google Scholar : PubMed/NCBI
17	Guo P, Lan J, Ge J, Nie Q, Guo L, Qiu Y and Mao Q: MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated. Exp Cell Res. 320:200–208. 2014. View Article : Google Scholar : PubMed/NCBI
18	Begg AC, Stewart FA and Vens C: Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 11:239–253. 2011. View Article : Google Scholar : PubMed/NCBI
19	Czochor JR and Glazer PM: microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal. 21:293–312. 2014. View Article : Google Scholar : PubMed/NCBI
20	Metheetrairut C and Slack FJ: MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev. 23:12–19. 2013. View Article : Google Scholar : PubMed/NCBI
21	Su H, Jin X, Zhang X, Xue S, Deng X, Shen L, Fang Y and Xie C: Identification of microRNAs involved in the radioresistance of esophageal cancer cells. Cell Biol Int. 38:318–325. 2014. View Article : Google Scholar : PubMed/NCBI
22	Wang P, Zhang J, Zhang L, Zhu Z, Fan J, Chen L, Zhuang L, Luo J, Chen H, Liu L, et al: MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Gastroenterology. 145:1133–1143.e12. 2013. View Article : Google Scholar : PubMed/NCBI
23	Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC cancer. 10:3672010. View Article : Google Scholar : PubMed/NCBI
24	Yu J, Wang Y, Dong R, Huang X, Ding S and Qiu H: Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol. 138:671–674. 2012. View Article : Google Scholar : PubMed/NCBI
25	Qu C, Liang Z, Huang J, Zhao R, Su C, Wang S, Wang X, Zhang R, Lee MH and Yang H: MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
26	Lee KM, Choi EJ and Kim IA: microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol. 101:171–176. 2011. View Article : Google Scholar : PubMed/NCBI
27	Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, et al: Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer. 126:2036–2048. 2010.PubMed/NCBI
28	Yan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo YY, Mao H, Hao C, Olson JJ, Curran WJ and Wang Y: Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One. 5:e113972010. View Article : Google Scholar : PubMed/NCBI
29	Yuan W, Xiaoyun H, Haifeng Q, Jing L, Weixu H, Ruofan D, Jinjin Y and Zongji S: MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis. Int J Med Sci. 11:691–696. 2014. View Article : Google Scholar : PubMed/NCBI
30	Wu Y, Liu GL, Liu SH, Wang CX, Xu YL, Ying Y and Mao P: MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis. J Radiat Res. 53:516–525. 2012. View Article : Google Scholar : PubMed/NCBI
31	Zhao L, Tang M, Hu Z, Yan B, Pi W, Li Z, Zhang J, Zhang L, Jiang W, Li G, et al: miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma. Oncotarget. 6:15995–16018. 2015. View Article : Google Scholar : PubMed/NCBI
32	Ahmad TA Tengku, Jaafar F, Jubri Z, Rahim K Abdul, Rajab NF and Makpol S: Gelam honey attenuated radiation-induced cell death in human diploid fibroblasts by promoting cell cycle progression and inhibiting apoptosis. BMC Complement Altern Med. 14:1082014. View Article : Google Scholar : PubMed/NCBI
33	In Lee S, Ji MR, Jang YJ, Jeon MH, Kim JS, Park JK, Jeon IS and Byun SJ: Characterization and miRNA-mediated posttranscriptional regulation of vitelline membrane outer layer protein I in the adult chicken oviduct. In Vitro Cell Dev Biol Anim. 51:222–229. 2015. View Article : Google Scholar : PubMed/NCBI
34	Liu SC, Chuang SM, Hsu CJ, Tsai CH, Wang SW and Tang CH: CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression. Cell Death Dis. 5:e14852014. View Article : Google Scholar : PubMed/NCBI
35	Goel HL and Mercurio AM: VEGF targets the tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
36	Osugi J, Kimura Y, Owada Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, et al: Prognostic impact of hypoxia-inducible miRNA-210 in patients with lung adenocarcinoma. J Oncol. 2015:3167452015. View Article : Google Scholar : PubMed/NCBI
37	Harriss-Phillips WM, Bezak E and Yeoh E: Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer. Br J Radiol. 84:903–918. 2011. View Article : Google Scholar : PubMed/NCBI
38	Gasparini P, Lovat F, Fassan M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, et al: Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci USA. 111:4536–4541. 2014. View Article : Google Scholar : PubMed/NCBI
39	Liu YJ, Lin YF, Chen YF, Luo EC, Sher YP, Tsai MH, Chuang EY and Lai LC: MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells. PLoS One. 8:e623832013. View Article : Google Scholar : PubMed/NCBI